| Literature DB >> 31616466 |
Divyanshu Srivastava1, Krishanu D Baksi1,2, Bhusan K Kuntal1,3,4, Sharmila S Mande1.
Abstract
The importance of understanding microbe-microbe as well as microbe-disease associations is one of the key thrust areas in human microbiome research. High-throughput metagenomic and transcriptomic projects have fueled discovery of a number of new microbial associations. Consequently, a plethora of information is being added routinely to biomedical literature, thereby contributing toward enhancing our knowledge on microbial associations. In this communication, we present a tool called "EviMass" (Evidence based mining of human Microbial Associations), which can assist biologists to validate their predicted hypotheses from new microbiome studies. Users can interactively query the processed back-end database for microbe-microbe and disease-microbe associations. The EviMass tool can also be used to upload microbial association networks generated from a human "disease-control" microbiome study and validate the associations from biomedical literature. Additionally, a list of differentially abundant microbes for the corresponding disease can be queried in the tool for reported evidences. The results are presented as graphical plots, tabulated summary, and other evidence statistics. EviMass is a comprehensive platform and is expected to enable microbiome researchers not only in mining microbial associations, but also enriching a new research hypothesis. The tool is available free for academic use at https://web.rniapps.net/evimass.Entities:
Keywords: human disease; literature mining; microbial association; microbiome; web server
Year: 2019 PMID: 31616466 PMCID: PMC6763948 DOI: 10.3389/fgene.2019.00849
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Figure 1Overview of the EviMass backend creation and utility of its various modules in understanding the intermicrobial and microbe–disease associations.
List of different microbe-related human diseases categorized by the organs they affect.
| Organs affected | Diseases | No. of diseases |
|---|---|---|
| Gut | End-stage renal disease (ESRD), kidney stones, diarrhea, liver cirrhosis, malnutrition, ileal Crohn disease (CD), necrotizing enterocolitis, colon cancer, infectious colitis, constipation, colitis, ulcerative colitis, Whipple disease, irritable bowel syndrome (IBS), gastroesophageal reflux, Crohn disease (CD), gastric and duodenal ulcer, inflammatory bowel disease (IBD), | 20 |
| Skin | Skin and mucosal infections, atopic dermatitis, psoriasis, guttate psoriasis, atopic sensitization, eczema, atopy | 7 |
| Lungs | Asthma, allergic asthma, recurrent wheeze, chronic obstructive pulmonary disease, cystic fibrosis | 5 |
| Brain | Multiple sclerosis, Parkinson’s disease, Schizophrenia, Autism, Depression | 5 |
| Urogenital | Urinary tract infection, bacterial vaginosis, polycystic ovary syndrome, preterm birth | 4 |
| Systemic | Type 1 diabetes, diabetes, type 2 diabetes, HIV/AIDS, obesity, systemic inflammatory response syndrome, allergic sensitization, allergy, ulcer, periodontitis | 10 |
| Total | 51 |
Figure 2Top 10 prominent microbial genera associated with diseases affecting various organs. Statistically significant (P < 0.05) genera are marked with a black asterisk (with Bonferroni-corrected P < 0.05 highlighted in red).
Figure 3Summary of the associated microbial genera count corresponding to each disease and the number of articles reporting the disease. The diseases are ordered based on the categories as listed in . Each category of disease is sorted based on the number of genera associations.
Figure 4Category-wise (organs affected by various diseases) bidirectionally clustered heat maps based on microbial associations. The top 20 persistent microbes across the six categories ( ) were chosen and used to generate bidirectionally clustered (UPGMA hierarchical clustering) heat map for each category. Euclidean distance was used as the measure of distance, and the values were normalized by rows (diseases).
Figure 5Flowchart describing the various steps involved in development of the EviMass backend.